Ascendis Pharma A/S (NASDAQ:ASND) Q3 2023 Earnings Call Transcript

Ascendis Pharma A/S (NASDAQ:ASND) Q3 2023 Earnings Call Transcript November 7, 2023

Ascendis Pharma A/S misses on earnings expectations. Reported EPS is $-2.88 EPS, expectations were $-2.63.

Operator: Hello, and welcome to Ascendis Pharma Third Quarter 2023 Earnings Conference Call and Webcast. Following the prepared remarks, there will be a question-and-answer period, instructions will be given at that time. I would now like to hand the conference over to Tim Lee, Investor Relations of...